Kymera Therapeutics

Kymera Therapeutics Appoints Elena Ridloff, CFA, to Board of Directors

WATERTOWN, Mass., March 16, 2021 (GLOBE NEWSWIRE) — Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing targeted protein degradation to deliver novel small molecule protein degrader medicines, today announced the appointment of Elena Ridloff, CFA, to its